Riccardo Polosa to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Riccardo Polosa has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.021
-
A review article on biosimilar infliximab SB2 in the treatment of rheumatoid arthritis. Immunotherapy. 2017 11; 9(14):1133-1142.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.